Dr. Christenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 North Broadway Street
Viragh BLDG 5th FL
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
Drexel University College of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
MD State Medical License 2016 - 2026
PA State Medical License 2024 - 2026
VA State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors Start of enrollment: 2022 Oct 06
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Revision of interpretation criteria to define microsatellite instability in mismatch repair-deficient neoplasms with subtle electropherogram changes.Ming-Tseh Lin, Eric Christenson, Suping Chen, Emily Adams, Matthew Bayes
American Journal of Clinical Pathology. 2025-03-06 - CD137 agonism enhances anti-PD1 induced activation of expanded CD8T cell clones in a neoadjuvant pancreatic cancer clinical trial.Janelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, Eric S Christenson, Ludmila V Danilova
Iscience. 2025-01-17 - Patterns of recurrence after curative intent hepatic resection for colorectal liver metastasis.Heng-Chung Kung, Christopher Shubert, Catherine Wilbur, Will Burns, Richard Burkhart
Journal of Gastrointestinal Surgery. 2024-12-01
Press Mentions
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024September 16th, 2024- NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual MeetingNovember 7th, 2022
- A Mitochondria-Anchored Isoform of the Actin-Nucleating Spire Protein Regulates Mitochondrial DivisionAugust 25th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
